Improving access to HIV prevention for young women in Uganda.
Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda.
This study is all about helping young women in Uganda, ages 15-24, access a medication called PrEP that can prevent HIV, by providing them with support from their peers and tools to improve their financial situation, so they can feel more confident and empowered to take care of their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11093664 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to pre-exposure prophylaxis (PrEP) for adolescent girls and young women aged 15-24 in Uganda, who are at a higher risk of HIV infection. The study aims to combine peer support interventions with economic empowerment strategies to address barriers such as stigma, financial constraints, and lack of social support that hinder PrEP uptake and adherence. By empowering these young women with both social and economic resources, the research seeks to improve their ability to manage their own health and reduce the risk of HIV. Participants will engage in programs designed to increase awareness and provide support in a community setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women aged 15-24 living in Uganda who are at risk of HIV infection.
Not a fit: Patients who are not at risk of HIV or who do not fall within the age range of 15-24 may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the uptake and adherence to PrEP among young women, thereby reducing HIV transmission rates.
How similar studies have performed: Previous research has shown that multi-level interventions combining peer support and economic empowerment can effectively improve health outcomes among youth affected by HIV.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Ssewamala, Fred M — Washington University
- Study coordinator: Ssewamala, Fred M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.